ArticleFrontiers in oncology2022

Proteoglycan-4 predicts good prognosis in patients with hepatocellular carcinoma receiving transcatheter arterial chemoembolization and inhibits cancer cell migration

Yuan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.